Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
indiana blog main
indiana top stories
5
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
national
alnylam pharmaceuticals
biomarin pharmaceutical
cancer
celgene
clinical trials
deals
fda
gene therapy
hemophilia
novartis
pharmacy benefit managers
sangamo therapeutics
2019
What
therapy
5
×
drug
approval
bio
fda
gene
roundup
moves
patients
treat
address
advanced
agency
aimmune
allergy
alnylam’s
approved
approves
aren’t
awarded
becker
bff
billions
blueprint
cancer
carries
certain
conference
deals
designed
developed
developers
devoted
disease
dollars
drugs
easl
eaton
form
friday
Language
unset
Current search:
therapy
×
" indiana top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
